Based on the complementary role of SLC8A1 and mtROS in promoting LKB1‐deficient uveal melanoma cell proliferation, we next investigated the therapeutic relevance of these pathways on tumor growth in vivo. The gene discussed is SLC8A1; the disease is uveal melanoma.